首页> 外文期刊>The Turkish journal of pediatrics >A novel de novo KCNQ2 mutation in a child with treatment-resistant early-onset epileptic encephalopathy
【24h】

A novel de novo KCNQ2 mutation in a child with treatment-resistant early-onset epileptic encephalopathy

机译:一种具有治疗耐药早盘性癫痫患者的儿童的新型Novo Kcnq2突变

获取原文
获取原文并翻译 | 示例
       

摘要

Mutations in KCNQ2 gene, encoding for voltage-gated K+ channel subunit, may result in a wide spectrum of early-onset epileptic disorders. The phenotype of the disease varies from "benign familial neonatal seizures" to "severe epileptic encephalopathies". In this report, we present a novel mutation [namely: c.683A>G (p.His228Arg)], as a presumable cause of severe infantile-onset neonatal seizures, in a 3-month old boy. The seizures have been poorly responsive to various pharmacological treatments, with phenytoin and carbamazepine presenting with the most favourable results so far. The study of our patient could help to further clarify the clinical manifestations of KCNQ2 mutations, revealing a previously unreported mutation.
机译:编码电压门控K+通道亚单位的KCNQ2基因突变可能导致广泛的早发性癫痫疾病。该病的表型从“良性家族性新生儿惊厥”到“严重癫痫性脑病”不等。在本报告中,我们在一名3个月大的男孩身上提出了一种新的突变[即:c.683A>G(p.His228Arg)],这可能是导致严重婴儿期新生儿癫痫发作的原因。癫痫发作对各种药物治疗的反应都很差,苯妥英和卡马西平的疗效最为理想。对我们患者的研究有助于进一步阐明KCNQ2突变的临床表现,揭示一种以前未报告的突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号